Clinical Trial Update: Lapatinib in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of lapatinib in combination with capecitabine in Japanese patients with metastatic breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Metastatic Breast Cancer, Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2011-09-05